MYST4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.153600E-01
Normal-vs-Stage2
1.214810E-01
Normal-vs-Stage3
4.774300E-02
Normal-vs-Stage4
9.961200E-01
Stage1-vs-Stage2
7.439300E-03
Stage1-vs-Stage3
4.119900E-02
Stage1-vs-Stage4
7.978800E-01
Stage2-vs-Stage3
2.144000E-01
Stage2-vs-Stage4
7.844100E-02
Stage3-vs-Stage4
6.968200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.488400E-01
Normal-vs-AfricanAmerican
5.042200E-01
Normal-vs-Asian
2.230200E-01
Caucasian-vs-AfricanAmerican
5.955200E-01
Caucasian-vs-Asian
3.975400E-01
AfricanAmerican-vs-Asian
3.845600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.582600E-01
Normal-vs-Female
2.516000E-01
Male-vs-Female
8.907000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.685200E-01
Normal-vs-Age(41-60Yrs)
5.390800E-01
Normal-vs-Age(61-80Yrs)
1.418030E-01
Normal-vs-Age(81-100Yrs)
6.074500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.893400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.166000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.447830E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.953900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.186430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.778800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.674000E-02
Normal-vs-Daily Drinker
1.018040E-01
Normal-vs-Weekly Drinker
1.951170E-01
Normal-vs-Occasional Drinker
6.712000E-01
Normal-vs-Social Drinker
6.184600E-01
Non Drinker-vs-Daily Drinker
9.344000E-01
Non Drinker-vs-Weekly Drinker
6.725000E-01
Non Drinker-vs-Occasional Drinker
1.588360E-01
Non Drinker-vs-Social Drinker
2.222000E-01
Daily Drinker-vs-Weekly Drinker
7.506600E-01
Daily Drinker-vs-Occasional Drinker
1.885830E-01
Daily Drinker-vs-Social Drinker
2.546400E-01
Weekly Drinker-vs-Occasional Drinker
3.468800E-01
Weekly Drinker-vs-Social Drinker
4.048200E-01
Occasional Drinker-vs-Social Drinker
9.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.796100E-02
Normal-vs-Grade 2
2.734000E-02
Normal-vs-Grade 3
2.751800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.750800E-01
Grade 1-vs-Grade 3
3.787600E-01
Grade 1-vs-Grade 4
9.796100E-02
Grade 2-vs-Grade 3
9.493600E-01
Grade 2-vs-Grade 4
2.734000E-02
Grade 3-vs-Grade 4
2.751800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.612000E-01
Normal-vs-NonDiabetic
1.550980E-01
Diabetic-vs-NonDiabetic
8.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.738430E-02
Normal-vs-NoPancreatitis
2.311000E-01
Pancreatitis-vs-NoPancreatitis
5.857800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.347800E-01
Normal-vs-N1
1.421170E-01
N0-vs-N1
5.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.436800E-01
Normal-vs-TP53-NonMutant
9.034800E-01
TP53-Mutant-vs-TP53-NonMutant
5.722400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
